GeneBio Systems
Recombinant Human IL-20RB Protein (Fc Tag)
Recombinant Human IL-20RB Protein (Fc Tag)
SKU:PKSH032574
Couldn't load pickup availability
Size: 50μg
Storage: Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping: This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Exp date: 12 months
Category ID_II: Recombinant Proteins
Category ID_III: Cytokines
Abbreviation: IL-20RB
Target Synonym: UNQ;PRO;MGC;DIRS;FNDC;fibronectin type III domain containing;IL-20R;IL20RB;DIRS1;FNDC6;IL-20R2;fibronectin type III domain containing 6;hCG_2022374;IL-20 receptor subunit beta;IL-20RB;IL-20R-beta;interleukin-20 receptor II;Interleukin-20 receptor subunit beta;MGC34923;UNQ557;PRO1114
Research Areas: Cancer;immunology
Conjugation:
Target Species: Human
Expression Host: HEK293 Cells
Application:
Fusion tag: C-Fc
UNIProt ID: Q6UXL0
Accession: Q6UXL0
Background: Interleukin-20 receptor subunit beta(IL20RB) is a single-pass type I membrane protein and belongs to the type II cytokine receptor family. It contains 2 fibronectin type-III domains. There are two kinds of type II cytokine receptors : cytokine receptors that bind type I and type II interferons; cytokine receptors that bind members of the interleukin-10 family (interleukin-10, interleukin-20 and interleukin-22). Type II cytokine receptors are similar to type I cytokine receptors except they do not possess the signature sequence WSXWS that is characteristic of type I receptors. They are expressed on the surface of certain cells, which bind and respond to a select group of cytokines. These receptors are related predominantly by sequence similarities in their extracellular portions that are composed of tandem Ig-like domains. The intracellular domain of type II cytokine receptors is typically associated with a tyrosine kinase belonging to the Janus kinase (JAK) family
Concentration:
Activity: Not validated for activity
Sequence: Asp30-Ala230
Purity: > 90 % as determined by reducing SDS-PAGE.
Formulation: Supplied as a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.
Reconstitution: Not Applicable
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 49.6 kDa
ObservedMW: 60-85 kDa
